Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. EQT sells HemoCue to Quest Diagnostics Inc.
Mandate

EQT sells HemoCue to Quest Diagnostics Inc.

February 19, 2007

EQT has signed an agreement with Quest Diagnostics Inc. regarding the sale of HemoCue. HemoCue AB develops, manufactures and markets diagnostic systems for decentralized analyses at doctors' offices, health centres, hospital reception areas and various hospital wards.

Vinge acted as advisor to EQT during the sale. Representatives from Vinge included Fredrik von Baumgarten, Tuula Tallavaara, Ulrich Ziche, Fredrik von der Esch and Louis de Geer.

Related

Vinge advises Baseload Capital in connection with an investment from Google

 Vinge has advised Baseload Capital Holding AB in connection with securing an investment from Google.
April 16, 2025

Vinge advises Acrinova in connection with the sale of properties

 Vinge advises Acrinova AB (publ) in connection with its sale of properties with an underlying property value of SEK 1.4 billion.
April 15, 2025

Vinge has advised Visa in connection with its investment in Mynt AB

 Vinge has advised Visa in connection with its investment in the Swedish fintech company Mynt AB ("Mynt"). The investment, which is part of Mynt's announced Series B funding round, underscores Visa's commitment to supporting innovative fintech solutions and improving payment experiences for businesses across Europe.
April 14, 2025